Mathias-Machado, M.C.; de Jesus, V.H.F.; Jácome, A.; Donadio, M.D.; Aruquipa, M.P.S.; Fogacci, J.; Cunha, R.G.; da Silva, L.M.; Peixoto, R.D.
Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know? Cancers 2024, 16, 679.
https://doi.org/10.3390/cancers16030679
AMA Style
Mathias-Machado MC, de Jesus VHF, Jácome A, Donadio MD, Aruquipa MPS, Fogacci J, Cunha RG, da Silva LM, Peixoto RD.
Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know? Cancers. 2024; 16(3):679.
https://doi.org/10.3390/cancers16030679
Chicago/Turabian Style
Mathias-Machado, Maria CecÃlia, Victor Hugo Fonseca de Jesus, Alexandre Jácome, Mauro Daniel Donadio, Marcelo Porfirio Sunagua Aruquipa, João Fogacci, Renato Guerino Cunha, Leonard Medeiros da Silva, and Renata D’Alpino Peixoto.
2024. "Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?" Cancers 16, no. 3: 679.
https://doi.org/10.3390/cancers16030679
APA Style
Mathias-Machado, M. C., de Jesus, V. H. F., Jácome, A., Donadio, M. D., Aruquipa, M. P. S., Fogacci, J., Cunha, R. G., da Silva, L. M., & Peixoto, R. D.
(2024). Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know? Cancers, 16(3), 679.
https://doi.org/10.3390/cancers16030679